The use of Schwann cell (SC) autotransplantation to influence neural repair in humans is dependent upon identifying mitogens that will effectively expand human Schwann cells (SCs) in culture. The recent purification and molecular cloning of glial growth factor (GGF), a potent mitogen for rat Schwann cells, has led to the recognition that a family of proteins (GGF/Hl?G/NDF/ARIA) are alternatively spliced products of a single gene. The heregulins (HRGs) have been characterized with respect to their influence on human breast cancer cell lines; here we examined whether the HRGs have mitogenic activity for human SCs. Using DNA synthesis assays and serial passaging of cells in culture, we demonstrate that HRG is an effective mitogen for human SCs and that, in the presence of agents that elevate CAMP, it is possible to expand these cells over multiple passages without overwhelming fibroblast contamination. One putative target for this family of proteins is pl 85e*s2, an EGF-like receptor tyrosine kinase that is encoded by the erbB2 protooncogene.
In this report we also demonstrate that the erbB2/3/4 messages as well as the erbB2/3 receptor proteins are present within cultured human SCs. The addition of HRG to human SCs results in tyrosine phosphorylation of a 185 kDa protein. In the presence of stimulatory concentrations of HRG, a blocking monoclonal antibody (2C4) to ~185**~* is capable of significantly inhibiting phosphorylation of a 185 kDa protein as well as the subsequent incorporation of 3H-thymidine within the human SC. These latter results implicate an important role for pl 85erbs2 in mediating the mitogenic response of human SCs to HRGs. [Key words: Schwann cells, human, heregulin, erbB2 receptor, proliferation, CAMP]
Schwann cells (SCs) are the principal support cells throughout the PNS, providing each axon with either ensheathment or a series of myelin segments. SCs originate from neural crest tissue early in embryonic development (Zimmer and Le Dourain, 1993) and migrate into the periphery along with growing axons. During this time, they undergo rapid cell division (Asbury, 1967) to accommodate an increasing number of peripheral axons (Lemke, 1990) . As they undergo their final differentiation, they stop dividing and remain essentially quiescent for the remainder of the life ofthe animal (Asbury, 1967) . Under pathological conditions such as peripheral nerve injury, demyelination, and tumorigenesis, the SC can be reactivated to enter the cell cycle (De Vries, 1993) . SCs produce a number of factors that are known to promote axonal regeneration. These include several well-characterized neurotrophic factors (Heumann et al., 1987; Acheson et al., 199 1; Friedman et al., 1992) cell adhesion molecules (Daniloff et al., 1986; Bixby et al., 1988) and basement membrane components (Bunge and Bunge, 1983) . SCs have a remarkable capacity to promote nerve fiber regeneration in both the PNS (Nadim et al., 1988; Guenard et al., 1992) and the CNS (David and Aguayo, 198 1; Paino and Bunge, 1991; GuCnard et al., 1993) . The construction of cellular prostheses consisting of human SCs could conceivably have several therapeutic applications in the repair of neural injuries.
The use of cell culture techniques to obtain an abundant source of autologous graft material from a small biopsy has been an approach that has already met with clinical success in providing human epidermal cells to cover extensive burns (Green et al., 1979; Gallico et al., 1984) . The construction of an autologous cellular prosthesis from human SCs is dependent upon the ability to obtain purified populations of SCs from adult peripheral nerve (Morrissey et al., 1991a) and to expand such cells in culture. As many agents that are effective for rat SC proliferation are minimally effective in inducing human SCs to divide (Morrissey et al., 1991a,b) , a central goal of our research has been to identify mitogens that are effective in specifically promoting human SC proliferation.
The purification of multiple forms of glial growth factor (GGF; Goodearl et al., 1993) which are potent mitogens for SCs (Lemke and Brockes, 1984) has allowed for the molecular cloning of this protein (Marchionni et al., 1993) . Genomic sequence analysis of GGF, as well as members of a number of recently characterized families of proteins [heregulins (HRG), Holmes et al., 1992 ; neu differentiation factor (NDF), Wen et al., 1992 ; and ACh receptor inducing activity (ARIA), Falls et al., 19931 , has rapidly led to the recognition that these proteins represent a family of alternatively spliced products of the same gene (Lemke, 1993) . The availability of human recombinant proteins (HRGs; Holmes et al., 1992) with similar sequences and receptor activation profiles as the newly characterized GGFs Marchionni et al., 1993) led us to test the influence of purified recombinant HRGs on human SC proliferation. Among the observations we report here are (1) a recombinant protein, HRG pl (residues 177-244), which contains the epidermal growth factor (EGF)-like domain of heregulin pl, is a potent mitogen for human SCs; (2) expansion of human SCs without overwhelming fibroblast contamination has been possible only when activators of adenyl cyclase are added to rHRG 01 ,77.244; and (3) the p185CrbSz receptor message and protein are present in human SCs and appear to be important in mediating the mitogenic effects of rHRG @l ,77.244 on human SCs.
Materials and Methods
Preparation ofpur.$ed human Schwann cellcultures. Human peripheral nerves were obtained from organ donors (14 months to 63 years; n = 15) by the transplant procurement team of the University of Miami School of Medicine. The nerves were used for subsequent study if the donors had a negative serology for infectious agents and if their past medical history was negative for any diseases predisposing to a peripheral neuropathy.
The nerves (phrenic, intercostal, or lumbosacral plexus) were harvested within 30 min of aortic clamping and stored in RPM1 (GIBCO Laboratories. Grand Island. NY) at 4°C for no more than 24 hr. Each peripheral nerve was prepared 'for culture according to the protocol of Morrissey et al. (199la) . This includes washing the nerve three times in Liebovitz's L15 (GIBCO). striouina the epineurium of the nerve, and removing individual fascicles from The remaining interfascicular epineurium. The fascicles were cut into explants 24 mm long and 6-10 explants were placed in 35 mm culture dishes. The prepared nerves were kept in a humidified atmosphere with 5% CO, and the medium was replaced twice per week with Dulbecco's Modified Eagle's Medium (DMEM; GIBCO) with 10% fetal calf serum (FCS). The individual explants were transplanted to new dishes after a confluent monolayer of predominantly fibroblasts (Fbs) had been generated as an outgrowth. This occurred in approximately 7-14 d.
After one to three transplantations the nerve explants were dissociated according to the protocol of Pleasure et al. (1986) . In brief, multiple explants-were pooled and placed in l-2 ml of an enzyme cocktail conSistine. of 1.25 U/ml disease (Boehrinaer Mannheim Biochemicals. Germanyj, 0.05% collage&se (Worthingion Biochemicals Corp., Freehold, NJ) and 15% FCS in DMEM. The explants were left in enzymes overnight and gently triturated the following morning with a straight glass borosilicate pipette, until individual explants could no longer be recognized. The cells were then washed in L15 and 10% FCS and plated on 100 mm culture dishes coated with 200 wm/ml poly-L-lysine (PLL; Sigma, St. Louis, MO).
The following day the cells were taken off the PLL-coated culture plates by rinsing twice with Ca'+ and Mgz+-free Hanks Balanced Salt Solution (HBSS; GIBCO) and exposing them to trypsin (0.05%) and EDTA (0.02%) (Sigma) in HBSS for 5-10 min at 37°C. The cells were collected and rinsed twice in L15 and 10% FCS, counted on a hemocytometer, and then diluted into a calculated volume of DMEM and 10% FCS (DlO). The cells were then seeded on Aclar (Allied Fiber and Plastics, Pottsville, PA) mini dishes coated with ammoniated collagen or PLL-coated culture dishes for subsequent study.
Human Schwann cell andjbroblast labeling indices. The central portions of mini dishes (see above) were seeded with 25-50,000 cells. The following day they were flooded with media containing DlO in the absence or presence of specified concentrations of mitogens [the truncated form of recombinant heregulin pl (rHRG 01 ,,,~,,,) or full-length recombinant heregulin 01 (Genentech, South San Francisco, CA); cholera toxin (CT, Sigma, St. Louis, MO); forskolin (Sigma)]. After 48 hr the same medium plus 3H-thymidine (0.5 rCi/ml) was added for exactly 24 hr to label nuclei that were synthesizing DNA. In some experiments, longer (48 or 72 hr) pulses of 3H-thymidine (0.1 &i/ml) were added to the cultures to determine if the population of human SCs under analysis was relatively homogeneous in their ability to respond to the added mitogens (rHRG 01 ,77.244r cholera toxin, and forskolin).
The cells were rinsed thoroughly with L15 to remove the radioactive medium and then fixed in 4% paraformaldehyde and permeabilized in 4% paraformaldehyde containing 0.03% T&on-X 100. The cultures were then blocked with 10% goat serum in L 15 and then incubated with anti-S100 antibody (1: 100; Dakopatts, Denmark) for 45 min, washed with Ll5, and incubated with a rhodamine-conjugated goat anti-rabbit secondary antibody (1:50; CappeVOrganon, Teknika Corp., West Chester, PA) for 35 min. The cultures were mounted tissue side up on glass slides with DPX mountant (BDH Laboratory, England), dipped in emulsion (Kodak emulsion NTB 2, Rochester, NY), stored at 4°C for 5 d, and then processed for autoradiographic development. A coverslip was applied to the cultures after adding a drop of a glycerol/phosphatebuffered saline solution (Citifluor Ltd., London, UK) containing 5 PM Hoechst dye (Hoechst 33342, Sigma). The Hoechst dye binds DNA and was used to image all the nuclei within the culture under the fluorescence microscope.
Human SCs were identified as SlOO and Hoechst positive; Fbs appeared as pleomorphic flat cells that were Hoechst positive but SIOO negative. The number of SCs and Fbs whose nuclei were labeled by autoradiographic grains was counted relative to the total number of these cells on 20 random fields for each sample (no less than 250 cells/ slide).
Expansion of human Schwann cells in culture. Human cells that had been dissociated from explants of adult peripheral nerve (see above) were seeded on PLL-coated dishes and were exposed to media containing DIO with either rHRG 81 ,77.244 (10 nM) alone or the triple mitogen cocktail consisting of rHRG Pl ,77.244 (10 nM), CT (100 &ml), and forskolin (1 WM). The initial seeding of cells onto culture mates is referred to as passage 0 (PO). The initial-SC purity was also determined by seeding the dissociated cells onto a collagen-coated mini dish and immunostaining the cells for SlOO. The medium was changed three times per week and when the cells had reached confluency, they were taken up from the culture dishes with the trypsin (O.OS%)/EDTA (0.02%) solution. The cells were collected, counted on a hemocytometer, and then split in half by seeding the cells onto two PLL-coated culture plates. At each passage a small aliquot of cells (< 10,000) was also seeded on a collagen-coated mini dish and immunostained for SlOO (see above) to determine the SC purity for that passage. The cells that had been split were again exposed to the above-described mitogens and processed in the same way when they had reached confluency.
Analysis of erbB2/3/4 expression in human Schwann cells. PolyA+ RNA was prepared from human SCs (1 x 106), which were previously expanded on the triple mitogens, using the Micro-Fast Track mRNA isolation kit (Invitrogen, San Diego, CA). RT-PCR reactions were performed with specific primer combinations for erbB2, erbB3, and erbB4 in a Perkin-Elmer 9600 instrument using reagents of the cDNA cycle kit (Invitrogen), and the PCR products were analyzed by gel electrophoresis. The gels were blotted onto nylon membranes, which were hybridized with internal oligonucleotide probes corresponding to the individual receptor proteins. This dual probing strategy (unique primer combinations and unique internal nucleotide probes) provided a high degree for specificity of this analysis. The probed blots were analyzed in a Fuji BAS BioImage Analyzer (Fuji Photo Film Co., Japan) image analysis system and the printouts of these screens are shown.
The primers used for erbB2 were, for upper, 5' AGGGAA-ACCTGGAACTCACC 3': lower. 5' TGGATCAAGACCCCTCCTTT 3'. The internal nucleotide probe was 5' GTGGGACCTGCCTC-ACTTGG 3'. The amplified fragment size was 298 base pairs (bp). The primers used for erbB3 were, for upper, 5' CAGGTGCTGGGC-TTGCTTTT 3'; lower, 5' GTGGCTGGAGTTGGTGTTAT 3'. The internal nucleotide probe was 5' CACTGTACAAGCTCTACGA-GAGGTGTGAGGTGGTGATGGG 3'. The amplified fragment size was 366 bp. The primers used for erbB4 were, for upper, 5' TCCAGCCCAGCGATTCTCAG 3'; lower, 5' GGCCAGTACAG-GACTTATGG 3'. The internal nucleotide probe was 5' TG-GAAACTTTGGACTTCAAGAACTTGGATTAAAGAAGTTG 3'. The amplified fragment size was 495 bp.
Western blot analysis. SCs were removed from tissue culture flasks using 2 mM EDTA in phosphate-buffered saline and gentle scraping. Harvested cells were pelleted by low-speed centrifugation, resuspended in buffer, and then counted using a hemocytometer. Cells were then repelleted and suspended in SDS-PAGE sample buffer. Samples for SDS-PAGE analysis were prepared such that the equivalent of 8 x IO4 cells per lane were loaded onto precast 4-l 2% gradient gels from Novex (San Diego, CA). The SDS gels were then electroblotted onto nitrocellulose. The nitrocellulose was blocked using 2% bovine serum albumin (BSA) in 25 mM Tris HCI buffer, pH 7.5, with 0.3 M NaCl and 0.5% It has no effect on Fb labeling index, but baseline Fb labeling under serum containing conditions (10% FCS) is substantially higher than even the highest SC labeling index observed with added rHRG 0 1 177.244 (10 nM). The experiment was repeated with five different donors (n = 5) whose average age was 19 years.
Tween-20. Blots were probed with an affinity-purified rabbit polyclonal to the extracellular domain (ECD) of the erbB2 protein (Fendly et al., 1990a ) at a final concentration of 0.8 &ml or an anti-erbB3 rabbit polyclonal antibody (Transduction Laboratories, Lexington, KY) used at a concentration of0.25 pg/ml. Immunoreactive bands were visualized after incubation with horseradish peroxidase-conjugated secondary (antirabbit; Tago, Burlingame, CA) antibody at a dilution of l:lO,OOO for erbB2 blots and 1:2000 for erbB3 blots using enhanced chemiluminescence with reagents obtained from Amersham (Buckinghamshire, England).
Tyrosine phosphorylation assays. Heregulin-stimulated phosphorylation assays using intact expanded human SCs were performed essentially as described by Holmes et al. (1992) with the following modifications. SCs were harvested as described above and resuspended in F12 (SO%)/DMEM (50%) containing 0.1% BSA. Cells were preincubated for 30 min at room temperature with 100 nM anti-p185erbs2 antibody (Fendly et al., 1990b) , 2C4 or 2H 11 (Genentech), or a control buffer solution. Incubations with rHRG 81 ,77.244 were then performed for an additional 8 min at room temperature. Reactions were terminated by the addition of SDS sample buffer. Samples (equivalent of 6 x lo4 cells per lane) for SDS-PAGE were loaded onto gradient gels and electroblotted onto nitrocellulose as described above. Blots were probed with anti-phosphotyrosine monoclonal antibody-horseradish peroxidase conjugate (Transduction Laboratories) and immunoreactive bands were visualized as described above.
Blocking rHRG @I,77~244 mitogenic signaling of human Schwann cells with an anti-p18PhB2 antibody. Mini dishes containing 25-30,000 cells obtained from primary dissociations of human peripheral nerve were fed with media containing DlO alone or DlO with the monoclonal antibodies 2C4 or 2Hll at a concentration of 100 nM for 30 min at room temperature. Without rinsing the cultures they were then fed with 10 nM rHRG 01 ,77.244 (l/10 vol) to give a final concentration of 1 nM. The cells were maintained at 37°C in 5% CO, for an additional 48 hr. Cells were pulse labeled for the subsequent 24 hr using media containing 'H-thymidine (0.5 pCi/ml) after reapplying the antibodies (100 nM) followed by rHRG pl 177.244 (1 nM) as described above. The cells were then fixed and immunostained for SlOO. The proportion of SCs and Fbs (S 100 negative cells) labeled for each condition was determined.
Statistical analysis. The data are presented either as the means + SEM (figures) or the means f SD (text and Table 1 ). The data were subjected to an analysis of variance. A commercially available software program, STATISTICA (StatSoft Inc., Tulsa, OK), was used for all statistical analysis.
Results
Recombinant heregulin stimulates the proliferation of human Sch wann cells Human SCs placed in culture without mitogens (Dl 0) have an extremely low labeling index (Fig. 1) . The addition of rHRG 01 ,77.244 to the cultures serves as a potent mitogen for the human Levi et al. l There is a synergistic effect of CT on rHRG /31,,,.,,,-induced SC labeling 0, < 0.01). The addition of forskolin to the rHRG 01 ,,,.,.,,,/CT mitogens significantly reduces Fb labeling (p < O.Ol), when compared to rHRG /31 ,,J.,,, alone, to a level in which SC labelina uarallels the Fb labelina index. The experiment was repeated with four different donors (n = 4) whose average age was 15 years.
SC. SC labeling, as measured by 3H-thymidine incorporation between 48 and 72 hr after exposure to this mitogen, increases with increasing concentrations of rHRG 61 ,77.244 in a dose-related manner. The lowest concentration in which a significant effect on SC labeling is seen is at 100 PM (p < O.Ol), and the highest labeling at 10 nM. No further increase in SC labeling was observed at doses of 100 nM (data not shown). The effective concentrations of rHRG p 1 ,77.244 on human SC labeling are similar to those concentrations that are effective for proliferation and tyrosine phosphorylation of human breast cancer cell lines (Holmes et al., 1992) . The data presented in Figure 1 were generated using a recombinant form of HRG /31 that encompasses the EGF-like domain of the protein (-7.9 kDa) and is designated rHRG /31 ,77.244. Similar experiments performed with purified full-length recombinant HRG @l (residues l-244, 45 kDa) expressed in mammalian cells had a nearly identical effect on human SC labeling indices (data not shown).
All assays are done in the presence of 10% FCS (DlO) and consequently the labeling of Fbs (Fig. 1, inset) is high (50-80 %) and is unaffected by the addition of rHRG /31 ,77.244. More importantly, the highest concentration of rHRG /I 1 ,77.244 (10 nM), in the presence of 10% FCS, results in an SC labeling index that is well below the Fb labeling index. The high labeling index seen with Fbs occurs because FCS contains a number of factors (Pastan et al., 1975; Olivera and Spiegel, 1993) , such as plateletderived growth factor (PDGF), that are known to be potent mitogens for Fbs and Fb cell lines (Heldin et al., 1989) . The presence of serum in the culture media also appears to be an important requirement for all of the soluble SC mitogens [GGF, Raff et al., 1978a ; but see Morgan et al., 199 1; Schubert, 1992;  transforming growth factor (TGF) p 1, Schubert, 1992; CT, for- skolin, PDGF, and fibroblast growth factor (FGF), Davis and Stroobant, 1990; Morgan et al., 199 1; for a review, see De Vries, 1993 [.
Heregulin synergizes with activators of adenyl cyclase to promote Schwann cell prolifeation Although rHRG @ 1 ,77.244 appeared to be a potent mitogen for human SCs, we tested whether the addition of activators of adenyl cyclase might enhance this effect. As shown in Figure 2 , CT alone had a marginal effect on the SC labeling index relative to rHRG P 1 ,77.244. However when rHRG pl ,77.244 and CT were added together, they had a synergistic effect on the human SC labeling index (p < 0.01) when compared to either agent alone. When forskolin, another activator of adenyl cyclase, was added to this combination of mitogens, no further increase in the SC labeling index was observed; however, Fb labeling was significantly inhibited (p < 0.01) when compared to the Fb labeling observed in the absence of any activators of adenyl cyclase. In a separate series of experiments (Table 1 ) the combination of rHRG P 1 177-244 and forskolin was also found to act in synergy to augment the 3H-thymidine labeling index of human SCs. The procedure that has been described to isolate large numbers of SCs from adult peripheral nerve (Morrissey et al., 199 la) invariably yields some Fbs. The inability to differentiate the human SC from the human Fb by morphologic criteria alone necessitates that we investigate any potential SC mitogen by combining 3H-thymidine autoradiography with immunostaining for a specific SC antigen (SlOO). Figure 3 clearly demonstrates that the combination of mitogens results in a higher SC labeling index when compared to rHRG ,f31,,,. 244 alone. As this was the only combination of mitogens (Rutkowski et al., 1992 ) that resulted in a higher labeling index for SCs than Fbs, these mitogens were used to expand human SCs in culture.
The influence of rHRG /3 1 ,77-244 alone or in combination with CT and forskolin on the expansion of cells dissociated from a number of peripheral nerve donors is summarized in Figure 4 . In accordance with the DNA synthesis results presented above (Figs. 2, 3 ), these data demonstrate that human SCs can be effectively expanded without overwhelming Fh contamination over the first four passages using a combination of the three mitogens. The addition of the aforementioned activators of adenyl cyclase is critically important in this pursuit, as rHRG pl ,77.244 alone results in only a modest increase in cell number and a substantial decrease in SC purity after only two passages. Concomitant to the increase in cell numbers (Fig. 4a ) between P3 and P4 in cells expanded with the triple mitogens, there is also a drop in the SC purity, indicating that the actual SC numbers are not increasing relatively faster between P3 and P4. Substantial increases in human SC numbers after the fourth passage have yet to been attained. To ascertain whether the human SCs isolated from peripheral nerve responded to the added mitogens in a relatively homogeneous manner, some cultures received long pulses of 3H-thymidine in the presence of the triple mitogens. In human SC preparations obtained from three different donors the average SC labeling index after 48 and 72 hr (Fig. 54,B) was 83.1% f 5.95 and 92.5% * 5.22, respectively. The ability to induce a majority of the SCs to enter the S-phase of the cell cycle over this time period confirms that a large subpopulation of unresponsive cells is unlikely to exist in these cultures. It has been previously determined (Levi et al., 1994a ) that primary dissociated human SCs often contain abundant intracellular inclusions that represent myelin debris (Fig. 6a,c) . The myelin within the human SCs prepared in culture is thought to be taken up during the process of in vitro "Wallerian degeneration" (Levi et al., 1994b) . In the absence of a mitogenic stimulus (i.e., 010) the inclusions are retained within the SCs. The accumulation of myelin debris within SCs that are unable to divide has also been observed in vivo when mitomycin C has been injected in the proximity of a nerve injury (Hall and Gregson, 1975; Hall, 1986; Pellegrino et al., 1986) . There is a rapid disappearance of SC myelin debris in culture upon exposure to the triple mitogens. This may represent an activation of myelin processing and/or dilution of the debris through serial divisions of the SC. After multiple passages, some of the human SCs accumulate intracellular inclusions (Fig. 6b,d ) quite dissimilar in appearance to the aforementioned debris in that they are clear, more rounded, and larger and are only infrequently encountered. . Cell number (a) and SC purity (b) over the first two passages (PO-P2; rHRG @l ,77.244r 10 nM; three donors with an average age of 14 years) or four passages ( 10 nM rHRG @ 1 177.244, 100 rig/ml CT, and lp~ forskolin; six donors with an average age of 22 years) of cells dissociated from human peripheral nerves. There was a greater increase in total cell number with the combination of mitogens (rHRG pl ,,,.,,,/CT/forskolin) when compared to rHRG PI,,,.,,, alone. SC purity is essentially maintained over the first four passages with the combination of mitogens consistent with the results obtained with 'H-thymidine labeling and unequivocally establishing the ability of human SCs to proliferate under these conditions. Also consistent with the autoradiographic studies is the rapid decrease in the SC purity even after the first passage when rHRG fll ,77.244 alone was added. There was a loss of adhesivity of cells to the PLL substrate at P2 when rHRG 01 ,77.244 alone was added.
ErbB2, erbB3 and erbB4 are expressed in human Schwann cells As shown in Figure 7A , transcripts for erbB2, erbB3, and erbB4 could be detected by RT-PCR analysis of human SCs. The blots in Figure 7A were generated using identical numbers of PCR cycles and internal oligonucleotide probes of similar specific activity. No cross-reactivity among the three receptor species was detected under these conditions; however, the erbB4 lane needed to be exposed in the image analyzer about 10 times longer than the erbB2 or erbB3 lanes. These data suggest that erbB2 and erbB3 are expressed at higher levels than erbB4 in mitogen-expanded human SCs. Since the heregulins were originally identified as specific activators of the p 1 8Yrbs2 receptor (Holmes et al., 1992) , it was of interest to determine whether erbB2 protein could be detected in human SCs. Western blot analysis using a polyclonal antibody to p 18 Yrbe2 in our human SC cell preparations is shown in Figure  7B . A 185 kDa band is clearly seen in lysates prepared from mitogen-expanded cultures (lane 2) of human SCs. For comparison a cell lysate from the breast carcinoma cell line MDA-MB-453, which is known to express moderate levels of p185erbsz (Lewis et al., 1993) , is also shown (lane 1). The specificity of the binding of this antibody to the ~185~~~~~ receptor is demonstrated by the ability of the purified erbB2 extracellular domain (ECD) to attenuate the signal successfully in lysates of both the human breast cancer and Schwann cells (lanes 3, 4) . These data agree with previous studies that demonstrated that ~185"'~, the rat homolog of erbB2 is present on rat SCs (Cohen et al., 1992; Jin et al., 1993) . Recently, it has been determined that HRG binds to the closely related receptor tyrosine kinase erbB3 (Carraway et al., 1994) , and activation of ~185~'~~~ requires coexpression of the erbB3 protein (Sliwkowski et al., 1994) . Thus, it was of interest to determine if ~180e'~~~ could also be detected in human SCs. Samples identical to those described above were immunostained with a polyclonal antibody directed to residues 169-336 of the ECD of the human erbB3 protein. This antibody will react with a lysate of insect cells expressing the bovine erbB3 protein as well as COS cells expressing human erbB3 but not erbB2 protein (Sliwkowski et al., 1994) but does not react with the erbB4 ECD on Western blots (L. Bald, J. Lofgren, B. M. Fendly, and M. X. Sliwkowski, unpublished observations). An immunoreactive band with a molecular size of -180-I 85 kDa is detected in the MDA-MB-453 cell lysate (Fig. 7C, lane 1) as this cell line is also known to express erbB3 (Kraus et al., 1993) . In agreement with RT-PCR analysis, an erbB3-immunoreactive band can also be detected in the mitogen-expanded human SCs (Fig. 7C, lane 2) . PI85 crhB2 is involved in heregulin signaling Although these data confirm that human SCs express erbB2, it was necessary to determine whether the response of human SCs to rHRG pl,,,.,,, was mediated through this receptor. In an effort to answer this question, tyrosine phosphorylation analysis was performed in the presence of monoclonal antibodies (2C4, 2H 11) to p 1 85erbs2. These well-characterized antibodies specifically recognize the extracellular domain of the human erbB2 receptor, and not the EGF receptor (Fendly et al., 1990b) or the erbB3/erbB4 receptors (L. Bald, B. M. Fendly, and M. X. Sliwkowski, unpublished observations). Some of these antibodies have antiproliferative effects in certain breast cancer lines that overexpress ~185~~~~~ (Hudziak et al., 1989; Lewis et al., 1993) . The 2C4 antibody (but not 2H11) is particularly effective in inhibiting heregulin activation of tyrosine phosphorylation and binding in cells that express erbB2 and erbB3 (Sliwkowski et al., 1994) . As shown in Figure 8 , a 185 kDa band is tyrosine phosphorylated in mitogen-expanded cultures (lane 2) after an 8 min incubation with rHRG @l ,77.244. The high basal level of protein tyrosine phosphorylation was likely due to the fact that these cells were not serum starved prior to the initiation of the phosphorylation assays. In these cells the phosphorylation signal was significantly diminished when SCs were preincubated with the blocking anti-p1 8Yrbez antibody 2C4 (lane 4). Tyrosine phosphorylation was not inhibited when SCs were preincubated with a control anti-p18YrbB2 antibody, 2Hll (lane 3). Previous studies have shown that the EC,, for the rHRG /31 ,,,.244-stimulated tyrosine phosphorylation of a 185 kDa in the breast carcinoma cell line MCF-7 was -0.05 nM (Holmes et al., 1992 ) and a maximal phosphorylation signal is obtained using 0.3 nM rHRG p1,77.244. A similar response appears to be occurring with the SCs, in that cells treated with 1 nM rHRG ,f31 ,77.244 (lane 2) or the control antibody (lane 3) 2H 11, followed by 0.3 nM rHRG pl ,,,.144 generate a tyrosine phosphorylation signal of nearly equal intensity. SC cultures derived from adult human peripheral nerve contain some Fbs, so it is important that it has been previously demonstrated that rat SCs but not Fbs specifically immunostain with anti-p18Sneu (Jin et al., 1993) . In addition, exposure of Fbs to ARIA and NDF in various cell culture systems (CorIas et al., 1993; Peles et al., 1993) does not result in the phosphorylation of the putative 185 kDa receptor. To determine if the effects of rHRG Pl ,77.244 on human SC division are also mediated by the ~185~~~~~ receptor, labeling indices were determined for SCs and Fbs in the presence and absence of the 2C4 antibody (Fig. 9) . As with the tyrosine phosphorylation assays, the 2C4 antibody, but not the control antibody (2H 1 l), significantly (p < 0.0 1) attenuated the rHRG 01 ,,,.2JJ-induced 3H-thymidine labeling of human SCs, but had no effect on the already high Fb labeling index. These results strongly suggest that the rHRG @1,7,.24J effect on human SC proliferation is at least partially mediated by the ~185~~~"~ receptor, and further supports the view that human Fb proliferation in this culture system does not involve this receptor. (Holmes et al., 1992) . their role in normal cell growth and differentiation is less clear. Several full-length cDNA clones that encode GGF proteins with SC mitogenic activity have been constructed from a human genomic library (Marchionni et al., 1993) . These GGF cDNA clones represent alternatively spliced mRNAs from a single gene. This gene also encodes the HRGs, NDF, and ARIA Marchionni et al., 1993) . Certain of the deduced amino acid sequences from the human GGF and heregulin cDNAs are identical (GGFHFB 1 and HRG 83; Holmes et al., 1992; Marchionni et al., 1993) , while others represent novel structures. NDF and ARIA gene products have been characterized in the rat and chicken, respectively (Wen et al., 1992; Falls et al., 1993) and differences in the deduced amino acid sequence of these proteins with heregulin represent a combination of evolutionary divergence as well as alternative splicing . The activities of GGF (Lemke and Brockes, 1984) and ARIA (Usdin and Fischbach, 1986) have been defined in the context of SC and muscle biology, respectively. Given the recently discovered relationship between HRG, NDF, GGF, and ARIA, it is important to define whether the activities of individual members of this family of related proteins are overlapping.
Discussion
Recombinant HRG proteins (Holmes et al., 1992) are ideal candidates to test as potential mitogens for human SCs: they are products of human genes, some of the HRG proteins are identical to deduced human GGF protein sequences, they appear to activate the same receptor family (Cohen et al., 1992; Holmes et al., 1992; Marchionni et al., 1993) and the receptor binding regions of the full-length protein have been characterized and can be uniquely expressed. While recombinant fulllength HRG p 1 is synthesized in mammalian cells, the truncated version (rHRG pl ,,i.z,,) is expressed in Escherichia coli and only comprises the nonglycosylated EGF-like structural unit and immediate flanking regions (Holmes et al., 1992) . The heregulins were initially purified from media conditioned rHRG @ 1 ,,7.2,4 is a potent mitogen for human SC as measured by a human breast tumor cell line based on their ability to by its ability to induce SCs to enter the S phase of the cell cycle. phosphorylate pl 8Yrbsz (H I o mes et al., 1992) . While this family However, the addition of HRG alone results in an SC labeling of proteins (CX and ps) are able to stimulate the growth of certain index that is well below the Fb labeling index in serum-conbreast cancer cell lines that overexpress the p18SerbB' receptor taining media. In an effort to define conditions that would permit expansion of human SCs, activators of adenyl cyclase were added. CT and forskolin have been shown to act in synergy with polypeptide growth factors (GGF, TGF PI, PDGF, FGF) in promoting SC division (Raff et al., 1978a; Porter et al., 1986; Ridley et al., 1989; Davis and Stroobant, 1990; Rutkowski et al., 1992) . While these agents were initially considered to be potent SC mitogens in themselves (Raff et al., 1978a,b) , recent evidence suggests (Davis and Stroobant, 1990 ; for a review, see Lemke, 1990 ) that they may simply modulate the response to polypeptide growth factors already present in serum (PDGF, TGF pl, FGF). In the case of PDGF, the addition of forskolin upregulates this mitogen's receptor within SCs (Weinmaster and Lemke, 1990) . The addition of CT or forskolin alone was relatively ineffective in inducing human SCs to enter the S phase of the cell cycle. This is in marked contrast to the high labeling index seen in rat SCs exposed to CT (Raff et al., 1978a) , and is consistent with the relative insensitivity of human SCs to mitogens that are effective for rat SCs. The addition of CT or forskolin to rHRG @I ,77.244 (10 nM) resulted in a marked synergy, such that the Experiments were repeated at least three times.
human SC labeling index essentially doubled when compared to rHRG pl ,77.244 alone. A similar effect was observed with pituitary extract or crude GGF preparations on dissociated rat SCs whether CT (Raff et al., 1978a) or forskolin (Porter et al., 1986) was used as the agent to elevate CAMP. In that GGF and rHRG pl ,77.244 are likely operating through homologous receptors (Holmes et al., 1992; Marchionni et al., 1993) whether in the human (p 1 8Fbbsz) or the rat (p 1 SW), the synergy of rHRG 81 ,77.244 and the activators of adenyl cyclase is consistent with the finding that addition of forskolin to GGF is capable of upregulating the expression of p18W message (Cohen et al., 1992) and a 185 kDa phosphorylated protein (Marchionni et al., 1993) in cultured rat SCs. 453 cells; lane 2, cell lysate of expanded human SCs. Blots were probed with an affinity-purified rabbit antibody directed against the extracellular domain (ECD) of pl 8Ybs'. Lanes 3 and 4 are identical to lanes 1 and 2 except antibody was preincubated with 60 rg of purified erbB2 ECD. Immunoreactive bands were visualized after incubation with horseradish peroxidase-conjugated secondary antibody. C, Western blot analysis for erbB3 expression. Lane 1, cell lysate of MDA-MB-453 cells; lane 2, cell lysate of mitogen-expanded human Schwann cells. Blots were probed with an affinity-purified rabbit antibody directed against residues 169-366 of the ECD of p 180 erb83. Immunoreactive bands were visualized as described above. The addition of both activators of adenyl cyclase (forskolin and cholera toxin) to rHRG pl,,,.,,, did not enhance the SC labeling index, but appeared to depress the Fb labeling index significantly when compared to rHRG 61 ,77.244 alone. In contrast to the SC, a rise in CAMP levels within human Fbs tends to inhibit cell division (Froehlich and Rachmeler, 1972; Hollenberg and Cuatrecasas, 1973; Heldin et al., 1989; Rutkowski et al., 1992) and may play a physiological role in signaling Fbs to cease growth at confluency in cell culture (Pastan et al., 1975) . The inhibition of human Fh labeling seen when the two activators of adenyl cyclase are added to rHRG 01 ,77.244 may result from the ability of forskolin to potentiate the CT induction of CAMP levels within cells (Barovsky and Brooker, 1985) . It is fortuitous that agents that elevate CAMP level within the two main cell types of dissociated human peripheral nerve explants, Schwann cells and fibroblasts, have opposite effects on cell division.
The ability to induce a majority (-90%) of the SCs to enter the S phase of the cell cycle after long pulses (48 and 72 hr) of jH-thymidine suggests that the human SCs, at least initially, are relatively homogeneous in their response to the added mitogens. While a subpopulation of rapidly dividing cells could potentially be counted twice during a 24 hr labeling index, most mammalian cells have a cell cycle of 18-24 hr (Alberts et al., 1989) . Preliminary observations suggest that the cell cycle time in human SCs that have been exposed to the triple mitogens is comparable.
The erbB2 protooncogene encodes a receptor tyrosine kinase, p18Yrbs2, with extensive homology to the human EGF receptor (Coussens et al., 1985) . Amplification and/or overexpression of erbB2 has been detected in a variety of human malignancies and is found frequently in human mammary carcinomas (Slamon et al., 1987) and breast tumor-derived cell lines (Lewis et al., 1993) . rHRG 61 ,77.244 has been shown to bind to human breast cancer cells and increase tyrosine phosphorylation pl 85erbs2 in these cells (Holmes et al., 1992) . The putative GGF receptor on rat SCs is also a 185 kDa protein that is phosphorylated on tyrosine residues when exposed to GGF (Marchionni et al., 1993) . Using specific oligonucleotide probes and antibodies, we demonstrate that both the erbB21erbB3 messages as well as proteins are present in cultured human SCs. While antibody reagents for p 1 80erb04'HER-4 were not available for this study, we could detect message for this receptor within the human SCs. Our assays also indicated that the addition of rHRG pl ,77.244 to the cells results in the phosphorylation of a 185 kDa protein on a tyrosine residue.
The importance of p 1 85erbs2 in transducing the heregulin signal in human SCs was confirmed using a specific blocking monoclonal antibody (2C4) to this receptor. Our results demonstrate that the 2C4 antibody inhibits tyrosine phosphorylation of a 185 kDa protein in human SCs and the incorporation of )Hthymidine within human SCs when these cells are exposed to rHRG @l ,77.244. These data provide strong evidence that pl 8gerbs2 is important in mediating the mitogenic effects of heregulin on human SCs.
It is known that HRG/NDF activation of ~185~~~~~ does not occur in all cells that express erbB2. It has been postulated that another component might be required for HRG/NDF activation of p 18 5erbe2 (Peles et al., 1993) . Two possible candidates that might mediate this responsiveness are the closely related receptor tyrosine kinases erbB3/HER-3 (Kraus et al., 1989; Plowman et al., 1990 ) and the newly discovered erbB4/HER-4 (Plowman et al., 1993a) . We have demonstrated here that a protein that is immunologically related to erbB3 and the erbB3 message can be readily detected in mitogen-stimulated human SCs. In a related study we have determined that HRG /31 ,77.244 will bind to the erbB3 protein (Carraway et al., 1994) and that, in the presence oferbB3, erbB2 is capable of binding HRG. Reconstitution of a high-affinity heregulin signaling receptor can be achieved by coexpression of erbB3 with erbB2 (Sliwkowski et al., 1994) . Recently, it has also been reported that a heregulin-like protein will bind and activate p 180 erbm'HER-4 (Plowman et al., 1993b) . Our experiments indicate that the message to erbB4/HER-4 can be detected in human SCs. Although erbB4 may be a receptor involved in heregulin signaling in human SCs, the ability to attenuate the mitogenic signal of heregulin by a blocking monoclonal antibody (2C4) that specifically recognizes erbB2 and not erbB3/4 suggests an important role for the erbB2 receptor in signal transduction.
It remains to be determined whether erbB2 may mediate this signal through the formation of heterodimers with either erbB3 or erbB4 or potentially another member of this family of receptors.
This study has established that rHRG pl,,,.,,,, a truncated member of the heregulin family, is a potent mitogen for human SCs isolated from peripheral nerve. It is particularly effective when combined with agents that elevate CAMP levels. In carefully counting cell numbers and determining SC purity when the mitogens are added, we have unequivocally established that the human SC can be induced to divide in culture and their numbers can be substantially increased. The ability to expand human SCs in culture combined with the recent demonstration of the functional expression of human SCs prepared in culture when transplanted into immune deficient rodents (Levi et al., 1994a) clearly advances the possibility of pursuing an autotransplantation paradigm in the repair of human central and peripheral nerve injuries. Several questions need to be addressed before such an autotransplantation paradigm could be used clinically; What is the fate of cultured human Schwann cells after longterm exposure to these potent mitogens (Sager, 1989; Goldstein, 1990) ? Will human SCs expanded in culture retain their ability to promote regeneration and myelinate regenerating axons (Feltri et al., 1992) ? Finally, will these human Schwann cells retain normal growth characteristics (and not form tumors when transplanted) after extensive expansion on mitogens (Langford et al., 1988) ?
